FY2024 EPS Estimate for ORIC Pharmaceuticals Cut by Analyst
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Investment analysts at Wedbush decreased their FY2024 EPS estimates for ORIC Pharmaceuticals in a report issued on Tuesday, November 12th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($1.82) per share for the year, down from their previous forecast of ($1.73). Wedbush […]
15 Nov 11:54 · The Markets Daily